Bayram, F.; Hegner, P.; Lauerer, A.-M.; Schildt, S.; Wermers, D.; Baier, M.J.; Mustroph, J.; Tafelmeier, M.; Provaznik, Z.; Schmid, C.;
et al. Myocardial DYRK1B Expression Is Increased in Patients with Impaired Cardiac Contractility and Sleep-Disordered Breathing. Antioxidants 2025, 14, 163.
https://doi.org/10.3390/antiox14020163
AMA Style
Bayram F, Hegner P, Lauerer A-M, Schildt S, Wermers D, Baier MJ, Mustroph J, Tafelmeier M, Provaznik Z, Schmid C,
et al. Myocardial DYRK1B Expression Is Increased in Patients with Impaired Cardiac Contractility and Sleep-Disordered Breathing. Antioxidants. 2025; 14(2):163.
https://doi.org/10.3390/antiox14020163
Chicago/Turabian Style
Bayram, Fatma, Philipp Hegner, Anna-Maria Lauerer, Sönke Schildt, Dominik Wermers, Maria Johanna Baier, Julian Mustroph, Maria Tafelmeier, Zdenek Provaznik, Christof Schmid,
and et al. 2025. "Myocardial DYRK1B Expression Is Increased in Patients with Impaired Cardiac Contractility and Sleep-Disordered Breathing" Antioxidants 14, no. 2: 163.
https://doi.org/10.3390/antiox14020163
APA Style
Bayram, F., Hegner, P., Lauerer, A.-M., Schildt, S., Wermers, D., Baier, M. J., Mustroph, J., Tafelmeier, M., Provaznik, Z., Schmid, C., Maier, L. S., Wagner, S., Arzt, M., & Lebek, S.
(2025). Myocardial DYRK1B Expression Is Increased in Patients with Impaired Cardiac Contractility and Sleep-Disordered Breathing. Antioxidants, 14(2), 163.
https://doi.org/10.3390/antiox14020163
